Kirstgen, M.; Lowjaga, K.A.A.T.; Müller, S.F.; Goldmann, N.; Lehmann, F.; Glebe, D.; Baringhaus, K.-H.; Geyer, J.
Hepatitis D Virus Entry Inhibitors Based on Repurposing Intestinal Bile Acid Reabsorption Inhibitors. Viruses 2021, 13, 666.
https://doi.org/10.3390/v13040666
AMA Style
Kirstgen M, Lowjaga KAAT, Müller SF, Goldmann N, Lehmann F, Glebe D, Baringhaus K-H, Geyer J.
Hepatitis D Virus Entry Inhibitors Based on Repurposing Intestinal Bile Acid Reabsorption Inhibitors. Viruses. 2021; 13(4):666.
https://doi.org/10.3390/v13040666
Chicago/Turabian Style
Kirstgen, Michael, Kira Alessandra Alicia Theresa Lowjaga, Simon Franz Müller, Nora Goldmann, Felix Lehmann, Dieter Glebe, Karl-Heinz Baringhaus, and Joachim Geyer.
2021. "Hepatitis D Virus Entry Inhibitors Based on Repurposing Intestinal Bile Acid Reabsorption Inhibitors" Viruses 13, no. 4: 666.
https://doi.org/10.3390/v13040666
APA Style
Kirstgen, M., Lowjaga, K. A. A. T., Müller, S. F., Goldmann, N., Lehmann, F., Glebe, D., Baringhaus, K. -H., & Geyer, J.
(2021). Hepatitis D Virus Entry Inhibitors Based on Repurposing Intestinal Bile Acid Reabsorption Inhibitors. Viruses, 13(4), 666.
https://doi.org/10.3390/v13040666